HEALY JAMES
HEALY JAMES, director at Rapport Therapeutics, Inc., has 1 open-market purchase worth $20,359,080 in company stock reported to the SEC in the last two years. The latest filing was reported on 2026-10-30.
In plain English
- A board director bought $20,359,080 of Rapport Therapeutics, Inc. stock with their own money. That is a big personal bet. (2026-10-30)
Filings
| Reported | Stock | What | Amount | Source |
|---|
| 2026-10-30 | RAPP
Rapport Therapeutics, Inc. | Bought | $20,359,080 | SEC filing |
All insider buys · Legends · Executives
TradeTrack shows public SEC filings for general information. It is not investment advice, an offer or a recommendation. Insiders buy and sell for many reasons, past results do not predict future results, and you can lose money.